Analyze your NGS data Today
Join Our Mission
Transform your Data for Actionable Insights
Our Services
Analyze your NGS data Today
Join Our Mission
Transform your Data for Actionable Insights
Our Services

Inborn Disease - A Global Challenge

350M+
Rare Diseases affect 350 million people worldwide, more than 175 million are children
80%
Origin of 80% rare diseases is genetic. 30% will not live to see their 5th birthday.
1 in 20
Rare Diseases affect 1 in 20 people in India. India is becoming a hub of rare diseases.

350M+

Rare Diseases affect 350 million people worldwide, more than 175 million are children

80%

Origin of 80% rare diseases is genetic. 30% will not live to see their 5th birthday.

1 in 20

Rare Diseases affect 1 in 20 people in India. India is becoming a hub of rare diseases.

“We are an international team working to transform your data for novel scientific discoveries.”

We empower researchers, clinicians, and innovators with accurate, fast, and actionable insights derived from complex sequencing data. From human genomics to microbial studies, our expertise ensures you unlock the full potential of your data for groundbreaking discoveries and impactful decisions.

Vgenomics is here to support you at every step of your data analysis by

350M+
Rare Diseases affect 350 million people worldwide, more than 175 million are children
80%
Origin of 80% rare diseases is genetic. 30% will not live to see their 5th birthday.
1 in 20
Rare Diseases affect 1 in 20 people in India. India is becoming a hub of rare diseases.

Analyze

Complex Datasets Analysis

Integrate

Multi-omics data integration for biomarker discoveries

Customization

Pipeline customization and optimization tailored to your project needs

Comprehensive Genomic Solutions for Genetic Diseases

Leverage our expert team to identify familial genetic disorders using WGS/WES analysis for accurate and timely diagnoses

Partner with Us

Advanced Workflows for Biomarker Discovery

Our advanced bioinformatics pipelines enable biomarker discovery and personalized treatment strategies integrating multi-omics data

Speak with Us

Customizable workflows

We empowers you to design and implement custom workflows that are perfectly aligned with your unique requirements.

Experience our Services

A Global Challenge

350M+
Rare Diseases affect 350 million people worldwide, more than 175 million are children
80%
Origin of 80% rare diseases is genetic. 30% will not live to see their 5th birthday.
1 in 20
Rare Diseases affect 1 in 20 people in India. India is becoming a hub of rare diseases.

300 Diseases Per Year

OMIM (Online Mendelian Inheritance in Man) is consistently adding 300 new genetic disorders per year since 2014

876,094 VUS

Clinvar has 876,094 Variants of Uncertain Significance (VUS) linked to 17,068 genes

90%

Arab population are carriers of at least one genetic disorder (Igenomix Report)

A Global Challenge

350M+
Rare Diseases affect 350 million people worldwide, more than 175 million are children
80%
Origin of 80% rare diseases is genetic. 30% will not live to see their 5th birthday.
1 in 20
Rare Diseases affect 1 in 20 people in India. India is becoming a hub of rare diseases.

876,094 VUS

Clinvar has 876,094 Variants of Uncertain Significance (VUS) linked to 17,068 genes

90%

Arab population are carriers of at least one genetic disorder (Igenomix Report)

300 Diseases Per Year

OMIM is consistently adding 300 new genetic disorders per year since 2014

Join us in revolutionizing NGS Data Analysis

We are a pioneering biotech company dedicated to revolutionizing NGS data analysis and delivering precision-driven insights for better healthcare outcomes

Join our Team

Locations

Quick Links

Social

Linkedin Instagram Youtube Facebook

Copyright © 2025 Vgenomics | All rights reserved

With a decade of diverse experience under his belt, Sameer Malik, an alumnus of the Delhi School of Economics, brings a robust blend of business strategy, finance, operations, and sales expertise to Vgenomics. From kick starting his career at KPMG to founding and scaling an e-commerce startup to over $1.5 million in annual revenues, and further contributing to the startup ecosystem through his involvement in Startup Nexus and Token Amigo, Sameer has navigated through various industries, consistently playing to his strategic and operational strengths. His rich entrepreneurial journey and strategic acumen are now channeled towards advancing Vgenomics' mission in the realm of rare inborn diseases diagnostics and therapeutic solutions.

A translational biologist based in Silicon Valley, Dr. Lal brings her expertise in data science, translational medicine, clinical biomarker, and CDx implementation across all phases of clinical trials development to Vgenomics. With over 150 patents to her name, she has substantial experience in regulatory interactions with both the drug and device divisions of the FDA, and companion diagnostics (Dx) programs.

After earning her doctorate from International Center of Genetic Engineering and Biotechnology (ICGEB), Dr. Sardar embarked on a mission to transform her research findings into practical applications that could benefit rare disease patients globally. She noticed a gap in dedicated solutions for the burgeoning hub of rare diseases in India, particularly those affecting children, and co-founded Vgenomics with Dr. Preeti to develop affordable diagnostics and therapeutic solutions.

Open chat
✉ Hey! Need Help?
Hello
Can we help you?